AXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD Gum
January 04, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Jan. 04, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK)...
AXIM® Biotech Receives Medical Ethical Committee Approval to Begin IBS Trial for Canchew Plus® CBDGum
December 06, 2016 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it received...
Photo Release -- Top Global Experts Join AXIM Biotechnologies Advisory Board
November 06, 2014 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Nov. 6, 2014 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM) is setting the "green standard" in the industrial hemp industry, tapping two world-renown experts to advise on the Company's...
Healthy Choices at Every Meal
June 20, 2013 05:00 ET
|
VSL#3
MISSION, KS--(Marketwired - Jun 20, 2013) - (Family Features) For families of the nearly 30 percent of the general population who suffer from irritable bowel syndrome, making healthy diet decisions...
Innovative Med Concepts Debuts Revolutionary iPhone(R) App Designed to Monitor Daily Health Habits and Improve Well-Being
May 22, 2012 08:00 ET
|
Innovative Med Concepts, LLC
TUSCALOOSA, AL--(Marketwire - May 22, 2012) - Privately held Innovative Med Concepts, LLC today announced the availability of UShapeHealth, a new, user-friendly, mobile health application for the...
Novogen's Investigational Drug for Inflammatory Bowel Disease Has Positive Results Following Phase Ib Trial
December 04, 2007 08:01 ET
|
Novogen, Limited
STAMFORD, CT and SYDNEY, AUSTRALIA--(Marketwire - December 4, 2007) - A recently completed
Phase Ib clinical trial of a new drug to treat inflammatory bowel disease
(IBD) indicates that treatment may...